Synergy between stimulator cells in the induction of the anti-Mlsa response

R H DeKruyff1, J Laning, M E Dorf

  • 1Children's Hospital, Stanford, Palo Alto, CA 94305.

Journal of Immunogenetics
|February 1, 1988
PubMed

We have identified two types of clones responsive to Mls determinants. One type responded vigorously to purified B cells from mice bearing Mlsa-stimulatory determinants. The other type, including clone Ly1-N5, responded vigorously to unfractionated spleen cells, but failed to respond to B cells alone or to spleen-adherent cells (SAC) alone from the Mlsa-bearing mice. Synergy between two stimulator cell types, B cells and SAC, was required to induce the Mls response of clone Ly1-N5. The failure of clone Ly1-N5 to respond to Mlsa-bearing B cells was reversed by the addition of SAC taken from mice bearing the Mlsa allele or the non-stimulatory Mlsb allele. B cells were required to provide the Mlsa determinant. The Mls response of clone Ly1-N5 is restricted by class II determinants shared by the H-2b, H-2d and H-2k haplotypes, but not the H-2q haplotype. The optimal response of the clone was obtained by using B cells bearing both Mlsa and the permissive H-2 alloantigen. However, complementation was also observed between B cells bearing Mlsa and the non-permissive Iaq and SAC bearing the nonstimulatory Mlsb, but a permissive Ia epitope, resulting in activation of the clone. Clone Ly1-N5 responds to Mlsa-bearing B cells only in the presence of SAC.(ABSTRACT TRUNCATED AT 250 WORDS)

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...